Drug Side Effects
Search
INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION
INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION
was reported 48 times
INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Radioactive Diagnostic Agent [EPC]
3
0.0010
1
Melanin Synthesis Inhibitor [EPC]
1
0.0009
2
Radiographic Contrast Agent [EPC]
7
0.0003
3
alpha-Glucosidase Inhibitor [EPC]
1
0.0002
4
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]
1
0.0001
5
Central Nervous System Stimulant [EPC]
4
0.0000
6
Proteasome Inhibitor [EPC]
3
0.0000
7
Ester Local Anesthetic [EPC]
1
0.0000
8
Non-Standardized Chemical Allergen [EPC]
1
0.0000
9
Integrin Receptor Antagonist [EPC]
1
0.0000
10
Amide Local Anesthetic [EPC]
1
0.0000
11
Estrogen [EPC]
2
0.0000
12
Partial Opioid Agonist [EPC]
1
0.0000
13
Acetylcholine Release Inhibitor [EPC]
1
0.0000
14
Antiarrhythmic [EPC]
1
0.0000
15
Aminosalicylate [EPC]
1
0.0000
16
Opioid Agonist [EPC]
2
0.0000
17
Azole Antifungal [EPC]
1
0.0000
18
Factor Xa Inhibitor [EPC]
1
0.0000
19
Kinase Inhibitor [EPC]
2
0.0000
20
Osmotic Laxative [EPC]
1
0.0000
21
GLP-1 Receptor Agonist [EPC]
1
0.0000
22
Thalidomide Analog [EPC]
1
0.0000
23
Corticosteroid [EPC]
2
0.0000
24
Benzodiazepine [EPC]
1
0.0000
25
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000